Malignant teratoma of the mediastinum

A teratoma is a tumour made from germ cells. Germ cells normally develop into eggs or sperm, but they can also form tissues such as cartilage, fat, skin, or bone.

The mediastinum is the space in the middle of the chest, between the lungs. It contains the heart, major blood vessels, windpipe, thymus, and lymph nodes. A tumour in this area can press on these structures as it grows.

Not every mediastinal teratoma is cancerous. A mature teratoma is usually non-cancerous, although it may still need removal because of its size or location. The term “malignant teratoma” can refer to several related findings:

• An immature teratoma containing less-developed tissue
• A teratoma with another malignant germ cell component
• A teratoma in which one tissue has changed into a different cancer, called somatic-type malignancy
• An older name for some mixed nonseminomatous germ cell tumours

These differences matter because treatment and outlook are not the same for every subtype. A specialist pathologist examines tumour tissue to identify exactly which components are present.

Small mediastinal tumours may cause no symptoms and may be found during imaging for another reason. Symptoms usually develop when the tumour becomes large enough to press on nearby structures.

Possible symptoms include:

• Chest pain, pressure, or a feeling of heaviness
• A persistent cough
• Shortness of breath or noisy breathing
• Difficulty lying flat because of breathlessness
• Fever, tiredness, or unexplained weight loss
• A hoarse voice or difficulty swallowing
• Swelling of the face, neck, or arms

Face or neck swelling may happen if the tumour blocks the superior vena cava, the large vein that returns blood from the upper body to the heart. This is called superior vena cava obstruction.

These symptoms have many possible causes. Having one does not mean that you have a mediastinal tumour.

The exact cause is usually unknown. During early development before birth, germ cells move through the body toward the future reproductive organs. One explanation is that a small number remain behind along the body’s midline and later form a tumour. The mediastinum is one place where this can happen.

There is no evidence that malignant teratomas are caused by an injury, diet, stress, or something you did.

Primary malignant mediastinal germ cell tumours occur most often in younger males, but teratomas can occur at other ages and in people of any sex.

Males with Klinefelter syndrome have an increased risk of primary mediastinal nonseminomatous germ cell tumours. Klinefelter syndrome is a chromosome condition in which a male has an extra X chromosome. Most people with a mediastinal teratoma do not have this syndrome.

A mediastinal germ cell tumour is not usually inherited directly from a parent. Genetic counselling may still be offered when a chromosome condition is suspected or there is an unusual personal or family history.

A chest X-ray may first show a mass, but a CT scan usually gives more detail. CT can show the tumour’s size, whether it contains fat, calcium, fluid, or solid tissue, and how close it is to the heart, lungs, and blood vessels. MRI may be used when more detail about nearby structures is needed.

Blood tests commonly include the tumour markers alpha-fetoprotein, or AFP, and beta-human chorionic gonadotropin, or beta-hCG. Lactate dehydrogenase, or LDH, may also help assess the amount of active tumour. These substances can be released by certain germ cell cancers.

A pure mature teratoma does not usually raise AFP or beta-hCG. A raised result can suggest that another malignant germ cell component is present. Normal markers do not rule out a malignant teratoma.

The diagnosis is confirmed by examining tumour tissue under a microscope. Tissue may come from a needle biopsy, a surgical biopsy, or removal of the mass. Because teratomas can contain several different tissues, a small sample may not represent the whole tumour. Specialist review and, sometimes, examination of the entire removed mass are important.

Further tests may include:

• CT scans of the abdomen and pelvis to check for spread
• Testicular examination and ultrasound in males
• Additional imaging guided by symptoms and the tumour subtype
• Repeat tumour-marker tests to establish a starting level

Examining the testes helps distinguish a primary mediastinal tumour from testicular cancer that has spread to the chest.

Treatment is planned by a team experienced in germ cell tumours and chest surgery. The plan is based on the pathology, tumour markers, whether nearby structures are involved, and whether the condition has spread.

Surgery is central to treating a teratoma when the mass can be removed safely. A mature teratoma may be treated with surgery alone. Chemotherapy does not reliably destroy mature teratoma tissue.

When the tumour contains a malignant nonseminomatous germ cell component, treatment usually includes platinum-based combination chemotherapy. Surgery may then be used to remove a remaining mass. Pathology can show whether that mass contains scar tissue, living cancer, or teratoma.

Sometimes tumour markers fall during chemotherapy while a teratoma-containing mass continues to grow. This is called growing teratoma syndrome. It is generally managed with surgical removal when feasible, rather than more of the same chemotherapy.

A teratoma with somatic-type malignancy contains a cancer resembling one that usually starts in another tissue, such as a sarcoma or carcinoma. These tumours may not respond well to standard germ cell chemotherapy. Complete surgery is especially important when possible, and additional treatment may be chosen according to the transformed cancer type.

Radiotherapy has a limited role because teratoma and many nonseminomatous germ cell tumours are not very sensitive to radiation. It may be considered in selected situations rather than as routine treatment.

Before treatment, you may be offered fertility preservation, such as sperm or egg storage. This is best discussed early because chemotherapy and major surgery can affect fertility.

The tumour can press on the lungs, airways, heart, oesophagus, or major blood vessels. This may lead to breathing problems, difficulty swallowing, fluid around the heart or lungs, or superior vena cava obstruction. Rarely, a teratoma can rupture or become infected.

Malignant components can spread to lymph nodes or other organs. The pattern of spread depends on the exact tissue type.

Treatment can also have lasting effects. Depending on the chemotherapy and surgery used, these may include reduced fertility, hearing changes, kidney problems, numbness in the hands or feet, lung effects, or reduced heart and lung capacity. Your care team can monitor for effects linked to the treatment you received.

Primary mediastinal nonseminomatous germ cell tumours have an uncommon association with certain blood cancers. New unexplained bruising, bleeding, repeated infections, or persistent fever should be assessed rather than saved for a routine appointment.

There is no known way to prevent a malignant teratoma of the mediastinum. It is thought to arise from abnormal germ cell development, not from a preventable exposure or behaviour.

Routine screening is not recommended for people without symptoms or a known high-risk condition. If you have Klinefelter syndrome, ask the clinician managing your care what follow-up is appropriate for you.

Treatment may take place over several months. Chemotherapy, recovery periods, scans, and possible chest surgery can interrupt work, education, exercise, and family life. Support with transport, finances, nutrition, and emotional health can be part of cancer care.

Tumour markers may be checked during and after treatment if they were raised at diagnosis. CT scans are also used to assess the mass and look for recurrence. A remaining mass does not automatically mean active cancer; it may be scar tissue or teratoma, so surgery or continued monitoring may be needed to clarify it.

Follow-up usually continues for years. Its timing is based on the tumour subtype, treatment, and response. Appointments may include examinations, tumour-marker tests, chest imaging, and checks for treatment-related effects.

Some people complete treatment and remain free of cancer. Others need further surgery or treatment because tissue remains or the cancer returns. A tumour containing somatic-type malignancy or disease that cannot be completely removed can be harder to treat.

Recovery after chest surgery and chemotherapy is often gradual. Breathlessness, tiredness, and reduced fitness may improve over months, but some long-term effects can remain. Rehabilitation, fertility support, and psychological care may help you return to daily activities.

Arrange a medical assessment if you develop a persistent cough, unexplained chest pressure, increasing breathlessness, difficulty swallowing, or swelling around your neck or face. These symptoms often have causes other than a tumour, but they should not be ignored.

If you have been treated, contact your cancer team promptly about a new lump, worsening chest symptoms, persistent fever, unexplained weight loss, unusual bruising, or side effects that are interfering with eating, drinking, walking, or sleep.

Seek emergency help for:

• Severe or rapidly worsening difficulty breathing
• Coughing up more than a small streak of blood
• Sudden swelling of the face or neck with breathing difficulty
• Fainting, confusion, blue or grey lips, or severe chest pain
• Fever during chemotherapy when your team has told you infection risk is high

Do not wait for a routine follow-up appointment when symptoms are severe or rapidly worsening.

Is a malignant mediastinal teratoma cancer?

Yes. “Malignant” means that cancerous tissue is present. However, pathology reports may use the term for different tumour patterns. Ask for the precise subtype, because an immature teratoma, a mixed germ cell tumour, and a teratoma with somatic-type malignancy may require different treatment.

Can malignant teratoma of the mediastinum be cured?

Sometimes. Cure is more likely when treatment controls the chemotherapy-sensitive cancer and any remaining teratoma can be completely removed. Spread, involvement of major chest structures, the pathology subtype, and response to chemotherapy all affect the outlook.

Why is a germ cell tumour in my chest?

Germ cells move through the body during early development before birth. It is thought that some cells may remain in the body’s midline instead of reaching the reproductive organs. These cells can later develop into a tumour. This does not mean that the tumour spread from the testes or ovaries, although those areas are checked during diagnosis.

Will I need surgery?

Many people do, because mature teratoma tissue does not respond well to chemotherapy. Surgery may be the first treatment for a removable teratoma or may follow chemotherapy for a malignant mixed tumour. Whether surgery is possible depends on the mass’s position and involvement of nearby organs and blood vessels.

Can it spread to other parts of the body?

Malignant components can spread. Possible sites depend on the exact germ cell or transformed cancer type. Staging scans and tumour markers help assess this. A mature teratoma itself usually grows locally, but its size can still cause serious pressure inside the chest.

Is it hereditary or contagious?

It is not contagious and is not usually inherited. Klinefelter syndrome is a recognised risk factor for primary mediastinal nonseminomatous germ cell tumours, but most affected people do not have an inherited family pattern.